Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

DSpace Repository

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Author: Kalmanti, L.; Saussele, S.; Lauseker, M.; Mueller, M. C.; Dietz, C. T.; Heinrich, L.; Hanfstein, B.; Proetel, U.; Fabarius, A.; Krause, S. W.; Rinaldetti, S.; Dengler, J.; Falge, C.; Oppliger-Leibundgut, E.; Burchert, A.; Neubauer, A.; Kanz, L.; Stegelmann, F.; Pfreundschuh, M.; Spiekermann, K.; Scheid, C.; Pfirrmann, M.; Hochhaus, A.; Hasford, J.; Hehlmann, R.
Tübinger Autor(en):
Kanz, Lothar
Published in: Leukemia (2015), Bd. 29, H. 5, S. 1123-1132
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2015.36
ISSN: 0887-6924
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)